FITC-Labeled Human CD5 Protein, Fc Tag (MALS verified)

Customer Reviews
Cat. No. / Size
Price
Qty
CD5-HF255-25ug
$330.00
CD5-HF255-200ug
$2040.00
ETA of in-stock products:2 business days

Product Details

  • Synonym

    CD5, LEU1

  • Source

    FITC-Labeled Human CD5, Fc Tag (CD5-HF255) is expressed from human 293 cells (HEK293). It contains AA Arg 25 - Pro 372 (Accession # P06127-1).

    Predicted N-terminus: Arg 25

    Request for sequence
  • Molecular Characterization

    CD5 Structure

    Other Tags and Version Biotin & Other Labeled Version

    This protein carries a human IgG1 Fc tag at the C-terminus.

    The protein has a calculated MW of 65.1 kDa. The protein migrates as 75-95 kDa and >116 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.

  • Conjugate

    FITC

    Excitation source: 488 nm spectral line, argon-ion laser

    Excitation Wavelength: 488 nm

    Emission Wavelength: 535 nm

  • Labeling

    The primary amines in the side chains of lysine residues and the N-terminus of the protein are conjugated with FITC using standard chemical labeling method. The residual FITC is removed by molecular sieve treatment during purification process.

  • Purity

    >90% as determined by SDS-PAGE.

    >90% as determined by SEC-MALS.

  • Formulation

    Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • Reconstitution

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • Storage

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please protect from light and avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 12 months in lyophilized state;
    2. -70°C for 3 months under sterile conditions after reconstitution.
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Customers Also Viewed

Performance Data

  • SDS-PAGE

    CD5 SDS-PAGE

    FITC-Labeled Human CD5, Fc Tag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 90%.

  • SEC-MALS

    CD5 SEC-MALS

    The purity of FITC-Labeled Human CD5, Fc Tag (Cat. No. CD5-HF255) is more than 90% and the molecular weight of this protein is around 135-165 kDa verified by SEC-MALS.

    Report
  • Bioactivity-ELISA

     CD5 ELISA

    Immobilized FITC-Labeled Human CD5, Fc Tag (Cat. No. CD5-HF255) at 1 μg/mL (100 μL/well) can bind Mouse Anti-CD5 Antibody, Mouse IgG1 with a linear range of 0.2-3 ng/mL (QC tested).

    Protocol
  • Bioactivity-FACS

     CD5 FACS

    5e5 of Anti-CD5 CAR-293 cells were stained with 100 μL of 3 μg/mL of FITC-Labeled Human CD5, Fc Tag (Cat. No. CD5-HF255) and negative control protein respectively. FITC signal was used to evaluate the binding activity (QC tested).

    Protocol

Customer Reviews
Writing Reviews

Background

T-cell surface glycoprotein CD5 is also known as Lymphocyte antigen T1/Leu-1 and LEU1,which is phosphorylated on tyrosine residues by LYN,so CD5 can create binding sites for PTPN6/SHP-1.CD5 may act as a receptor in regulating T-cell proliferation. CD5 is expressed at various developmental and activation stages on human B cells.CD5 is a well established negative regulator of TCR and BCR signalling.CD5-positive cells may also prevent the emergence of autoimmunity by provision of cytokines such as IL-10. Development,selection and function of different B- and T-cell subsets or their preferential survival may be directly or indirectly dependent on different glycan structures associated with CD5 or CD5-like molecules.

Recent Advances

 
Drug Development Progress
  • English Name:

    T-cell surface glycoprotein CD5

  • Category:

  • Approved Drugs:

    0 Details

  • Drugs in Clinical Trials:

    8 Details

  • Highest Development Stage:

    Phase 2 Clinical

Contact Us
Drug Candidate Licensing
More
  • Basic Product Information
  • Product Details
  • Customers Also Viewed
  • Performance Data
  • Customer Reviews
  • Background